Insider trades
John A. Lewicki, Chief Officer of Mereo BioPharma Group MREO, has filed 0 purchases and 4 sales on the open market. The latest trade was on 02/01.
John A. Lewicki
Chief Scientific Officer
- Company
- Mereo BioPharma Group MREO
- First filing
- 24/01/26
- Trades
- 13 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- No record
- Last trade
- 02/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MREO | Open-market sale | 24/09/12–24/09/13 | 24/09/16 | 16,149 sh2 trades | $4.30avg. | $69,451.78 | −17.0% |
MREO | Open-market sale | 24/06/25–24/06/26 | 24/06/27 | 24,224 sh2 trades | $3.48avg. | $84,344.16 | −33.2% |